Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aciclovir extended release - Vectans Pharma

Next Previous
X
Search
Drug Profile

Aciclovir extended release - Vectans Pharma

Alternative Names: Aciclovir - Onxeo; Aciclovir extended release - Onxeo; Aciclovir Lauriad®; Aciclovir muco-adhesive buccal tablet - Onxeo; Acyclovir extended release - Onxeo; Acyclovir Lauriad® 50mg (Sitavir) - Onxeo; BA 021; Labiriad; Sitavig; Sitavir®

Latest Information Update: 06 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BioAlliance Pharma
  • Developer Cipher Pharmaceuticals; Vectans Pharma
  • Class Antivirals; Eye disorder therapies; Hypoxanthines; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Herpes labialis

Highest Development Phases

  • Marketed Herpes labialis

Most Recent Events

  • 02 Jul 2024 Bayer completes a phase III trial for Herpes labialis in USA (Buccal) (NCT05098938)
  • 09 Aug 2022 Launched for Herpes labialis (Recurrent) in South Korea (Buccal), prior to August 2022
  • 09 Aug 2022 Navamedic expects to launch the drug in the Nordics and Benelux in the first half of 2024

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top